1. Safety and efficacy of autologous hematopoietic stem‐cell transplantation following natalizumab discontinuation in aggressive multiple sclerosis. (14th December 2018) Authors: Mariottini, A.; Innocenti, C.; Forci, B.; Magnani, E.; Mechi, C.; Barilaro, A.; Nistri, R.; Fani, A.; Saccardi, R.; Massacesi, L.; Repice, A. M. Journal: European journal of neurology Issue: Volume 26:Number 4(2019) Page Start: 624 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗